medullary thyroid cancer glp-1 Glucagon-like peptide 1 receptor agonist use and risk of cancer: Scandinavian cohort study Dr Medica || Clinical MCQ

Understand the place in therapy of GLP-1 and GIP analogues for glycaemic control in type 2 diabetes mellitus

Given that the half-life of SGLT2 inhibitors varies from 11 to 13 hours, it seems reasonable to withhold these medications for three days (or five half-lives) before elective surgery

If you notice mood shifts after starting semaglutide, reporting these changes promptly helps ensure your treatment plan stays aligned with your mental health goals

Weight loss medications that have been tested and approved through regulatory pathways are safe and effective for individuals experiencing indications such as obesity, diabetes, MASH, obstructive sleep apnea, and in some cases heart disease, says Dr